Wall Street Analysts Predict a 106.45% Upside in Profound Medical (PROF): Here's What You Should Know

Core Viewpoint - Profound Medical (PROF) shares have increased by 2.7% recently, closing at $7.91, with a mean price target of$16.33 indicating a potential upside of 106.5% according to Wall Street analysts [1] Group 1: Price Targets and Analyst Consensus - The mean price target consists of three short-term estimates with a standard deviation of $3.79, where the lowest estimate of$12 suggests a 51.7% increase, and the highest estimate predicts a 140.2% surge to $19 [2] - A low standard deviation among price targets indicates strong agreement among analysts regarding the stock's price movement direction and magnitude, serving as a starting point for further research [7] - Analysts' growing optimism about PROF's earnings prospects is reflected in the upward revisions of EPS estimates, which correlate strongly with near-term stock price movements [9] Group 2: Earnings Estimates and Zacks Rank - Over the past 30 days, one earnings estimate for PROF has increased, leading to a 7.1% rise in the Zacks Consensus Estimate, with no negative revisions [10] - PROF holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating a strong potential upside [11]